A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/2001
11/08/2001	CA2407797A1 Methods for treatment of diseases associated with inflammation under non-ischemic conditions
11/08/2001	CA2407785A1 Use of .alpha.-msh and epo for preventing or treating ischemic conditions
11/08/2001	CA2407746A1 Proteases
11/08/2001	CA2407587A1 Ppar.gamma. modulators
11/08/2001	CA2407435A1 Rna metabolism proteins
11/08/2001	CA2407337A1 A medicinal aerosol formulation
11/08/2001	CA2407294A1 Plant extract of the olea europaea species as no-synthase inhibitor and uses
11/08/2001	CA2406755A1 A gene therapy system and method using alpha-msh and its derivatives
11/08/2001	CA2405611A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
11/08/2001	CA2403901A1 29 human secreted proteins
11/07/2001	EP1152055A1 ADAMTS polypeptides, nucleic acids encoding them, and uses therof
11/07/2001	EP1152004A1 Phosphonic acid derivatives having carboxypeptidase b inhibitory activity
11/07/2001	EP1152002A1 Pyrrole derivatives and cell death inhibitors
11/07/2001	EP1151101A1 Prostacyclin-stimulating factor-2
11/07/2001	EP1151099A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy
11/07/2001	EP1151002A1 Antibodies specific to kdr and uses thereof
11/07/2001	EP1150996A1 New amidinobenzylamine derivatives and their use as thrombin inhibitors
11/07/2001	EP1150974A1 Heterocyclic derivatives as inhibitors of factor xa
11/07/2001	EP1150963A1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them
11/07/2001	EP1150958A1 Substituted pyrazole carboxylic acids used to combat anaemias
11/07/2001	EP1150950A2 Anthranilic acid derivatives
11/07/2001	EP1150948A1 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
11/07/2001	EP1150728A1 Methods and compositions for use in perfusion applications
11/07/2001	EP1150704A1 New use of melagatran
11/07/2001	EP1150702A2 Utilization of orosomucoid in order to produce a pharmaceutical preparation
11/07/2001	EP1150658A2 Method for controlling liposome size
11/07/2001	EP0815139B1 Thrombin inhibitors based on the amino acid sequence of hirudin
11/07/2001	EP0799048B1 Body fluid replacement solution
11/07/2001	CN1321149A New crystal modification III of torasemide
11/07/2001	CN1320689A Expression system using autotomy of fusion protein, and reduced polypeptide
11/07/2001	CN1320446A Process for preparing staltic medicine from Taiwan Beautyberry leaf
11/07/2001	CN1320438A Process for preparing medicines
11/06/2001	US6313298 Spiro-indolines as Y5 receptor antagonists
11/06/2001	US6313170 For therapy of nutritional iron-deficiency anemia, blood loss anemia and hemolytic anemia in humans
11/06/2001	US6313151 As inhibitors of factor xa and are used as anticoagulants in mammals
11/06/2001	US6313122 As inhibitors of factor xa and are used as anticoagulants in mammals
11/06/2001	US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
11/06/2001	US6312753 Cocoa components, edible products having enriched polyphenol content, methods of making same and medical uses
11/06/2001	US6312665 Aerosol formulations for buccal and pulmonary application
11/01/2001	WO2001081622A2 Diagnosis of diseases associated with dna repair
11/01/2001	WO2001081590A2 Protein phosphatases
11/01/2001	WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	WO2001081573A1 Edg8 receptor, its preparation and use
11/01/2001	WO2001081540A2 Growth factor which acts through erb b-4 rtk
11/01/2001	WO2001081415A2 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/01/2001	WO2001081405A2 Methods and compositions for the prevention and treatment of anemia
11/01/2001	WO2001081377A2 Integrin/adhesion antagonists
11/01/2001	WO2001081363A1 Novel compounds
11/01/2001	WO2001081348A1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO[3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS
11/01/2001	WO2001081346A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
11/01/2001	WO2001081312A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001	WO2001081311A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
11/01/2001	WO2001080937A1 Drug delivery device for insertion in the vagina, rectum or nasal cavity
11/01/2001	WO2001080873A2 Thrombopoietin receptor modulating peptide
11/01/2001	WO2001080870A2 Compositions derived from cranberry and grapefruit and therapeutic uses therefor
11/01/2001	WO2001044239A3 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
11/01/2001	WO2001041762A3 Valdecoxib compositions
11/01/2001	WO2001041761A3 Valdecoxib compositions
11/01/2001	WO2001036609A8 Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
11/01/2001	WO2001036608A8 Reversibly inactivated acidified plasmin
11/01/2001	WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof
11/01/2001	WO2001034640A3 Peptide (virip) which inhibits a circulating virus in humans and the use thereof
11/01/2001	WO2001032866A3 Hybrid adaptor receptors
11/01/2001	WO2001029049A3 Imidazole derivatives as phosphodiesterase vii inhibitors
11/01/2001	WO2001013924A8 Novel compositions for controlled release of a biologically active agent, and the preparation thereof
11/01/2001	WO2001010847A3 Novel integrin receptor antagonists
11/01/2001	WO2001005937A3 Conversion of a watson-crick dna to a hoogsteen-paired duplex
11/01/2001	WO2000066111A9 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/01/2001	WO2000032632A9 Allo- and auto-reactive t-cell epitopes from rhesus protein and their use
11/01/2001	US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
11/01/2001	US20010036932 Cardiovascular disorders
11/01/2001	US20010036927 Complexing
11/01/2001	US20010036500 For enriching foods or beverages, anemia treatment
11/01/2001	US20010036456 Administering Protein C
11/01/2001	US20010036454 Transfection of lung tissue
11/01/2001	US20010036451 Embolic compositions
11/01/2001	CA2690018A1 Methods and compositions for the prevention and treatment of anemia
11/01/2001	CA2407493A1 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
11/01/2001	CA2407449A1 Novel compounds
11/01/2001	CA2407445A1 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo¬3,4-b\|-pyridines as cyclin dependent kinase inhibitors
11/01/2001	CA2407167A1 Thrombopoietin receptor modulating peptide
11/01/2001	CA2407086A1 Integrin/adhesion antagonists
11/01/2001	CA2406725A1 Edg8 receptor, its preparation and use
11/01/2001	CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	CA2406264A1 Protein phosphatases
11/01/2001	CA2405348A1 Novel compositions derived from cranberry and grapefruit and therapeutic uses therefor
11/01/2001	CA2405170A1 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
10/2001
10/31/2001	EP1149906A1 Thrombopoietin receptor modulating peptide
10/31/2001	EP1149114A2 Polypeptides involved in immune response
10/31/2001	EP1149104A2 Pyrrolobenzodiazepine carboxyamide vasopressin agonists
10/31/2001	EP1149103A1 Thienylbenzoylbenzazepines as vasopressin agonists
10/31/2001	EP1149099A2 Imidazo[4,5-c]-pyridine-4-on-derivatives
10/31/2001	EP1149097A2 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
10/31/2001	EP1149096A2 Tricyclic pyridine n-oxides vasopressin agonists
10/31/2001	EP1149091A1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
10/31/2001	EP1149083A1 Morpholinobenzamide salts
10/31/2001	EP1149069A1 Phenylglycine derivatives
10/31/2001	EP1148882A1 Pharmaceutical combination of progesterone and folic acid
10/31/2001	EP1148879A2 Use of pyrazole carboxamides
10/31/2001	EP1148875A1 Methods and compositions to enhance white blood cell count

1 ... 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 ... 671